Similar articles

• Journal Watch review of Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.

  Jain S. Jain S. J Am Psychoanal Assoc. 2014 Feb;62(1):113-5. doi: 10.1177/0003065114525236. J Am Psychoanal Assoc. 2014. PMID: 24610762 No abstract available.
• Evidence for short-term psychodynamic psychotherapy for depression.

  Abbass AA, Shedler J, Town JM. Abbass AA, et al. J Clin Psychiatry. 2012 May;73(5):718; author reply 718-20. doi: 10.4088/JCP.12lr07633. J Clin Psychiatry. 2012. PMID: 22697196 No abstract available.
• Failure rate and "professional subjects" in clinical trials of major depressive disorder.

  Shiovitz TM, Zarrow ME, Shiovitz AM, Bystritsky AM. Shiovitz TM, et al. J Clin Psychiatry. 2011 Sep;72(9):1284; author reply 1284-5. doi: 10.4088/JCP.11lr07229. J Clin Psychiatry. 2011. PMID: 21951988 No abstract available.
• New antidepressants for older people: a critical review of the evidence base.

  Katona C. Katona C. Encephale. 2008 Apr;34 Suppl 2:S71-S76. doi: 10.1016/S0013-7006(08)73284-6. Encephale. 2008. PMID: 18675006 Review. No abstract available.
• Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons.

  Eckert L, Lançon C. Eckert L, et al. BMC Psychiatry. 2006 Jul 24;6:30. doi: 10.1186/1471-244X-6-30. BMC Psychiatry. 2006. PMID: 16867188 Free PMC article. Review.